EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 29 July 2021

News

EFPIA response to the European Commission's consultation on the revision of EU rules on medicines...
29 July 2021

Science, economics, and policy coalesce to inform investment decisions. It follows that these three dimensions must... Read more

Events

DIA Pharmacovigilance Strategies Workshop
07 September 2021 (Virtual event)

A unique opportunity to engage in the sharing of good practices between industry representatives and seek the advice... Read more

Building the European Health Union together for better public health in Europe
08 September 2021 (Virtual Event)

An event from Vaccines Europe Read more

Health Systems after COVID-19 - how can the industry contribute to strengthened resilience?...
24 September 2021 (Virtual event)

In the effort to making health systems more resilient to future pandemics and other shocks, both public institutions... Read more

How can we close the East-West healthcare investment gap in Europe?
04 October 2021 (Virtual event)

Public healthcare spending in CEE countries has grown over time, but at a slower pace than GDP growth and today the... Read more

We published

Addressing unmet needs in extremely rare and paediatric-onset diseases: how the biopharmaceutical...
28 July 2021 (Publications)

A report by Dolon Read more

Challenges and facilitators in the development of orphan and paediatric medicines
28 July 2021 (Publications)

Illustrative case studies on five different therapies developed in collaboration with the Office of Health Economics.... Read more

Connecting Healthcare Guide 2021
15 July 2021 (Publications)

Best practice examples of collaboration between patients, patient organisations and industry Read more

Health Systems after COVID-19 – charting a course for a healthier Europe
14 July 2021 (News & Events)

EFPIA believes that once we emerge from this crisis, we should not only rebuild our economies and get our societies... Read more

What we are reading

New EFPIA President Hubertus von Baumbach on Building Back Better from COVID & a Healthier...
On 23 July 2021 (PharmaBoardroom)

Boehringer Ingelheim’s Hubertus von Baumbach, the newly appointed president of the European Federation of Pharmaceutical... Read more

Superbug pandemic threatens to undo medical progress
On 23 July 2021 (Euractiv)

It’s never easy to focus on more than one crisis at a time. But, as vaccines begin to point the way out of the COVID-19... Read more

EU action to turn the AMR tide looks at different incentive models
On 23 July 2021 (Euractiv)

EU policymakers are being urged to consider the full range of new incentive systems and pilot innovative approaches... Read more

WC11 PODCAST JULY 2021
On 22 July 2021 (WC11 Maastricht)

Kirsty Reid, Director of Science Policy at the European Federation of Pharmaceutical Industries and Associations (EFPIA)... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu